Last reviewed · How we verify
NCT06751511
The Effect of Inspiratory Muscle Warm-up on Decreased Diffusing Capacity for Carbon Monoxide After Maximal Exercise in Athletes
NA trial testing General warm-up in Athlete in 28 participants. Not yet recruiting.
15 January 2025
Quick facts
| Lead sponsor | Emre Karaduman |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 28 |
| Start date | 15 January 2025 |
| Primary completion | 15 January 2025 |
| Estimated completion | 30 January 2025 |
Drugs / interventions tested
- General warm-up
- Inspiratory muscle warm-up (Placebo - %15)
- Inspiratory muscle warm-up (%40 IMW)
Conditions studied
- Athlete — all drugs for Athlete →
Sponsor
Emre Karaduman
Who can join
Adults 18 to 24, male only, with Athlete. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effects of inspiratory muscle warm-up (IMW) on the gas exchange capacity of the lungs (DLCO) and its potential contribution to recovery and athletic performance in elite athletes from various disciplines. The study hypothesizes that the decline in respiratory muscle capacity following high-intensity exercise, which negatively affects ventilation, diffusion, and oxygen transport, may be ameliorated through specific IMW protocol. A placebo-controlled, randomized, crossover, and double-blind design will be utilized, involving 28 elite male athletes from endurance, power, skill-based, and mixed disciplines. Participants will complete three warm-up protocols: General Warm-up (GW), General Warm-up combined with IMW at 40% resistance intensity (GW+IMW40%), and a placebo condition (GW+IMWplacebo). Measurements will include respiratory muscle strength, DLCO (assessed at post-2, 30, 60, 90, and 120 minutes), respiratory function, and cardiorespiratory parameters during maximal exercise. This study is unique as it aims to detail the micro-level effects of IMW on pulmonary diffusion mechanisms and performance outcomes, providing novel insights into the ameliorative effects of IMW on respiratory function post-exercise. Additionally, it seeks to expand understanding of the mechanistic basis of IMW's benefits on both pulmonary diffusion capacity and athletic performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06751511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Athlete
Currently open trials in the same condition.
- NCT07510893 — Augmented Feedback Effects on Shoulder Rotator Performance · NA · recruiting
- NCT07288892 — Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery · NA · recruiting
- NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
- NCT07136038 — Preventing Athlete Under-fueling Through Nutrition. · NA · recruiting
- NCT06881745 — Lifestyle and Nutrition Evaluation in Physically Active People and Athletes · recruiting
Other Emre Karaduman trials
Trials by the same sponsor.
- NCT06736236 — The Effect of Respiratory Muscle Warm-up on Pulmonary Diffusion Capacity in Athletes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06751511 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Emre Karaduman
- Last refreshed: 30 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06751511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing